Biotech Values

[GD]

PTLA: norseml post more yesterday on why Bevyxxa is a better drug
than Xarelto and Eliqius. norseml "spent close to 10 years designing
antithrombotics and about 30 years designing drugs."

"In conclusion, Betrixaban is a much a better molecular entity than
Riveroxaban (Xarelto) and somewhat better molecular entity than Apixaban
(Eliquis). This superiority is already evidenced in equivalent trial
results. It won't be long before physicians will realize this because, the
practitioner will see this first hand with much more dramatic impact than
when presented with a bunch of numbers from clinical trials. Won't be long
before Betrixaban eats into Xarelto's market, and hang tough or make minor
inroads into Eliquis' market."



https://www.investorvillage.com/smbd.asp?mb=18338&mn=2087&pt=msg&mid=17883679